125 related articles for article (PubMed ID: 9109408)
1. Characterization and receptor specific toxicity of two diphtheria toxin-related interleukin-3 fusion proteins DAB389-mIL-3 and DAB389-(Gly4Ser)2-mIL-3.
Liger D; vanderSpek JC; Gaillard C; Cansier C; Murphy JR; Leboulch P; Gillet D
FEBS Lett; 1997 Apr; 406(1-2):157-61. PubMed ID: 9109408
[TBL] [Abstract][Full Text] [Related]
2. Phe496 and Leu497 are essential for receptor binding and cytotoxic action of the murine interleukin-4 receptor targeted fusion toxin DAB389-mIL-4.
Lakkis F; Landgraf B; Wen Z; Strom TB; Murphy JR
Protein Eng; 1992 Apr; 5(3):241-8. PubMed ID: 1409544
[TBL] [Abstract][Full Text] [Related]
3. Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells.
vanderSpek JC; Mindell JA; Finkelstein A; Murphy JR
J Biol Chem; 1993 Jun; 268(16):12077-82. PubMed ID: 8505330
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 4 receptor targeted cytotoxicity: genetic construction and in vivo immunosuppressive activity of a diphtheria toxin-related murine interleukin 4 fusion protein.
Lakkis F; Steele A; Pacheco-Silva A; Rubin-Kelley V; Strom TB; Murphy JR
Eur J Immunol; 1991 Sep; 21(9):2253-8. PubMed ID: 1679715
[TBL] [Abstract][Full Text] [Related]
6. DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactions.
vanderSpek JC; Sutherland JA; Ratnarathorn M; Howland K; Ciardelli TL; Murphy JR
J Biol Chem; 1996 May; 271(21):12145-9. PubMed ID: 8647806
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of murine cytokine fusion toxin, diphtheria toxin390-murine interleukin-3 (DT390-mIL-3), with bone marrow progenitor cells.
Chan CH; Blazar BR; Greenfield L; Kreitman RJ; Vallera DA
Blood; 1996 Aug; 88(4):1445-56. PubMed ID: 8695865
[TBL] [Abstract][Full Text] [Related]
8. The diphtheria toxin transmembrane domain as a pH sensitive membrane anchor for human interleukin-2 and murine interleukin-3.
Liger D; Nizard P; Gaillard C; vanderSpek JC; Murphy JR; Pitard B; Gillet D
Protein Eng; 1998 Nov; 11(11):1111-20. PubMed ID: 9876934
[TBL] [Abstract][Full Text] [Related]
9. Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein.
Jean LF; Murphy JR
Protein Eng; 1991 Dec; 4(8):989-94. PubMed ID: 1817263
[TBL] [Abstract][Full Text] [Related]
10. Genetic construction and characterization of the diphtheria toxin-related interleukin 15 fusion protein DAB389 sIL-15.
vanderSpek JC; Sutherland J; Sampson E; Murphy JR
Protein Eng; 1995 Dec; 8(12):1317-21. PubMed ID: 8869645
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
[TBL] [Abstract][Full Text] [Related]
12. Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells.
Kiyokawa T; Williams DP; Snider CE; Strom TB; Murphy JR
Protein Eng; 1991 Apr; 4(4):463-8. PubMed ID: 1881872
[TBL] [Abstract][Full Text] [Related]
13. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
14. Site-directed and deletion mutational analysis of the receptor binding domain of the interleukin-6 receptor targeted fusion toxin DAB389-IL-6.
Jean LF; Waters CA; Keemy D; Murphy JR
Protein Eng; 1993 Apr; 6(3):305-11. PubMed ID: 8506265
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP.
vanderSpek JC; Sutherland JA; Zeng H; Battey JF; Jensen RT; Murphy JR
Cancer Res; 1997 Jan; 57(2):290-4. PubMed ID: 9000570
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of soluble and functional fusion protein DAB
Zarkar N; Nasiri Khalili MA; Khodadadi S; Zeinoddini M; Ahmadpour F
Biotechnol Appl Biochem; 2020 Mar; 67(2):206-212. PubMed ID: 31600001
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity.
Liu TF; Urieto JO; Moore JE; Miller MS; Lowe AC; Thorburn A; Frankel AE
Exp Hematol; 2004 Mar; 32(3):277-81. PubMed ID: 15003313
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cells.
Sweeney EB; Foss FM; Murphy JR; vanderSpek JC
Bioconjug Chem; 1998; 9(2):201-7. PubMed ID: 9548535
[TBL] [Abstract][Full Text] [Related]
19. Diphtheria toxin-based recombinant murine IL-2 fusion toxin for depleting murine regulatory T cells in vivo.
Wei M; Marino J; Trowell A; Zhang H; Stromp Peraino J; Rajasekera PV; Madsen JC; Sachs DH; Huang CA; Benichou G; Wang Z
Protein Eng Des Sel; 2014 Sep; 27(9):289-95. PubMed ID: 25147093
[TBL] [Abstract][Full Text] [Related]
20. The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2.
Hu HY; Huynh PD; Murphy JR; vanderSpek JC
Protein Eng; 1998 Sep; 11(9):811-7. PubMed ID: 9796831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
